Lack of Support for the Use of VMAT-2 Inhibitors for the Treatment of Tics in Tourette Syndrome

Mark S Baron^{1

2}

Affiliations

¹ Virginia Commonwealth University Parkinson's Movement Disorders Center, Virginia Commonwealth University Health System, Richmond, Virginia.
² Southeast Parkinson's Disease Research, Education and Clinical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.

Free article

Comment

Mark S Baron. JAMA Netw Open. 2021.

Free article

. 2021 Oct 1;4(10):e2129704.

doi: 10.1001/jamanetworkopen.2021.29704.

Mark S Baron^{1

2}

¹ Virginia Commonwealth University Parkinson's Movement Disorders Center, Virginia Commonwealth University Health System, Richmond, Virginia.
² Southeast Parkinson's Disease Research, Education and Clinical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia.

No abstract available

Comment on

Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E. Coffey B, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2129397. doi: 10.1001/jamanetworkopen.2021.29397. JAMA Netw Open. 2021. PMID: 34661664 Free PMC article. Clinical Trial.